Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

BA-Salz should be considered as harmful after single oral exposure (LD50, rat for Bay u 3405: 1000 - 1250 mg/kg bw).

Key value for chemical safety assessment

Acute toxicity: via oral route

Link to relevant study records
Reference
Endpoint:
acute toxicity: oral
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
key study
Study period:
1988
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Read-across, GLP study, no guideline mentioned
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
GLP compliance:
yes
Test type:
standard acute method
Limit test:
no
Species:
rat
Strain:
Wistar
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Harlan Winkelmann, Borchen, Germany
- Strain: Bor:WISW (SPF Cpb)
- Age at study initiation: adult (187 - 203 g)
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: at least 5 days
Route of administration:
oral: gavage
Vehicle:
other: 0.5% tylose mucilage
Details on oral exposure:
- Application volume: 20 mL/kg bw
Doses:
Males: 1000, 1250, 1600, 1500, 2500, 4000, and 5000 mg/kg bw
Females: 630, 1000, 1250, 1600, and 2500 mg/kg bw
No. of animals per sex per dose:
5
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: at least once daily (clinical signs, mortality) or once weekly (weight gain)
- Necropsy of survivors performed: yes
Statistics:
none
Sex:
male/female
Dose descriptor:
LD50
Effect level:
1 000 - 1 250 mg/kg bw
Based on:
test mat.
Mortality:
Doses of 1250 to 4000 mg/kg bw in males and 1000 to 1250 mg/kg bw led to 20 to 80% mortality. All males died in the 5000 mg/kg bw group and all females died in the 1600 and 2500 mg/kg bw groups.
Clinical signs:
other: No clinical signs were seen in males of the 1000 mg/kg bw group. Uncoordinated gait, labored breathing, reduced motility and narrow palpebral fussures were seen in females of the 630 mg/kg bw group and in most of the animals of the higher dose groups. At
Gross pathology:
severe disturbance of microcirculation, especially of liver, spleen and lung may explain the symptoms (liver and spleen nearly black, lung dark red)
Interpretation of results:
harmful
Remarks:
Migrated information
Executive summary:

The acute oral toxicity of Bay u 3405 was moderate with an LD50 value of 1000 - 1250 mg/kg bw in rats. Mortality occurred at doses of 1000 to 1250 mg/kg bw and higher. Clinical signs were observed as uncoordinated gait, labored breathing, reduced motility and narrow palpebral fussures in females of the 630 mg/kg bw group and in most of the animals of the higher dose groups. In animals that died during the observation period a black discoloration of liver and spleen, and a dark-red discoloration of lung was detected as a consequence of severe disturbance of the microcirculation.

Endpoint conclusion
Endpoint conclusion:
adverse effect observed
Quality of whole database:
The study is GLP compliant and is of high quality

Acute toxicity: via inhalation route

Endpoint conclusion
Endpoint conclusion:
no study available

Acute toxicity: via dermal route

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

BA-Salz is the butyl ammonium salt of Ramatroban (Bay U 3405).

The acute oral toxicity of Bay u 3405 was moderate with an LD50 value of 1000 - 1250 mg/kg bw in rats. Mortality occurred at doses of 1000 to 1250 mg/kg bw and higher. Clinical signs were observed as uncoordinated gait, labored breathing, reduced motility and narrow palpebral fussures in females of the 630 mg/kg bw group and in most of the animals of the higher dose groups. In animals that died during the observation period a black discoloration of liver and spleen, and a dark-red discoloration of lung was detected as a consequence of severe disturbance of the microcirculation.


Justification for selection of acute toxicity – oral endpoint
most relevant study on rats

Justification for classification or non-classification

Based on the study results (oral LD50: 1000 - 1250 mg/kg bw) a classification with R22 (harmful if swallowed) according to Directive 67/548/EEC or with Acute Toxicity Cat. 4 (H302:harmful if swallowed) according to Regulation (EC) No. 1272/2008 (CLP) is required.